The DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Niture, S. K., Jain, A. K., & Jaiswal, A. K. (2009) · Journal of Cell Science · doi:10.1242/jcs.058537 · Cited by 192
RetractedZhang, S., Kan, Q., Xu, Y., Zhang, G., & Zhu, L. D. (2013) · Mediators of Inflammation · doi:10.1155/2013/736085 · Cited by 43
RetractedKan, Q., Zhang, S., Xu, Y., Zhang, G., & Zhu, L. D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.031 · Cited by 35
RetractedFree radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., & Choi, A. M. K. (2000) · Nature Medicine · doi:10.1038/74680 · Cited by 2,153
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Gold, R., Kappos, L., Arnold, D. L., Bar-Or, A., Giovannoni, G., Selmaj, K., Tornatore, C., Sweetser, M. T., Yang, M., Sheikh, S. I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114287 · Cited by 1,733
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
Prevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,401
ANTIOXIDANT AND ANTI-INFLAMMATORY PROPERTIES OF CURCUMIN
Menon, V. P., & Sudheer, A. R. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_3 · Cited by 1,392
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Fox, R. J., Miller, D. H., Phillips, J. T., Hutchinson, M., Havrdova, E., Kita, M., Yang, M., Raghupathi, K., Novas, M., Sweetser, M. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206328 · Cited by 1,355
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
(2002) · PubMed · Cited by 1,190
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601758 · Cited by 1,074
BALOGUN, E., HOQUE, M., GONG, P., KILLEEN, E., GREEN, C. J., FORESTI, R., ALAM, J., & MOTTERLINI, R. (2003) · Biochemical Journal · doi:10.1042/bj20021619 · Cited by 1,036
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., Lambers Heerspink, H. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306033 · Cited by 1,030
Blood-brain barrier tight junction permeability and ischemic stroke
Sandoval, K. E., & Witt, K. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.005 · Cited by 964
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
Barone, F. C., & Feuerstein, G. Z. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00001 · Cited by 930
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Gilgun-Sherki, Y., Melamed, E., & Offen, D. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00019-3 · Cited by 838
Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., & Ting, J. P.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607260103 · Cited by 818
Oxidative stress response and Nrf2 signaling in aging
Zhang, H., Davies, K. J. A., & Forman, H. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.036 · Cited by 804
Small Molecule Modulators of Keap1‐ Nrf2‐ ARE Pathway as Potential Preventive and Therapeutic Agents
Magesh, S., Chen, Y., & Hu, L. (2012) · Medicinal Research Reviews · doi:10.1002/med.21257 · Cited by 760
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
Oxidative damage in multiple sclerosis lesions
Haider, L., Fischer, M. T., Frischer, J. M., Bauer, J., Hoftberger, R., Botond, G., Esterbauer, H., Binder, C. J., Witztum, J. L., & Lassmann, H. (2011) · Brain · doi:10.1093/brain/awr128 · Cited by 753
Minocycline selectively inhibits M1 polarization of microglia
Kobayashi, K., Imagama, S., Ohgomori, T., Hirano, K., Uchimura, K., Sakamoto, K., Hirakawa, A., Takeuchi, H., Suzumura, A., Ishiguro, N., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.54 · Cited by 742
Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1521-05.2005 · Cited by 713
Martin, D., Rojo, A. I., Salinas, M., Diaz, R., Gallardo, G., Alam, J., de Galarreta, C. M. R., & Cuadrado, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309660200 · Cited by 700
DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 670
Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., & Hayes, J. D. (2013) · Oncogene · doi:10.1038/onc.2012.388 · Cited by 657
Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641
Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
Rodrigo, R., Fernandez-Gajardo, R., Gutierrez, R., Matamala, J., Carrasco, R., Miranda-Merchak, A., & Feuerhake, W. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050015 · Cited by 640
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
Zhang, M., An, C., Gao, Y., Leak, R. K., Chen, J., & Zhang, F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.09.003 · Cited by 617
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
Barber, S. C., & Shaw, P. J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.018 · Cited by 617
What is the role of protein aggregation in neurodegeneration?
Ross, C. A., & Poirier, M. A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1742 · Cited by 604
Begum, A. N., Jones, M. R., Lim, G. P., Morihara, T., Kim, P., Heath, D. D., Rock, C. L., Pruitt, M. A., Yang, F., Hudspeth, B., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137455 · Cited by 604
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 600
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565
Flier, J. S., Underhill, L. H., Martin, J. B., & Gusella, J. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152006 · Cited by 550
Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Huang, H.-C., Nguyen, T., & Pickett, C. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220418997 · Cited by 539
Fitzgerald, D. C., Zhang, G.-X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. M., Gran, B., Ciric, B., & Rostami, A. (2007) · Nature Immunology · doi:10.1038/ni1540 · Cited by 529
Bloom, D. A., & Jaiswal, A. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307633200 · Cited by 525
Salazar, M., Rojo, A. I., Velasco, D., de Sagarra, R. M., & Cuadrado, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513737200 · Cited by 521
A Potential Role of the Curry Spice Curcumin in Alzheimers Disease
Ringman, J., Frautschy, S., Cole, G., Masterman, D., & Cummings, J. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585882 · Cited by 518
Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology
Frautschy, S. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00300-1 · Cited by 514
Oxidative stress in Huntington’s disease
Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508
Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway
Kwak, M.-K., Wakabayashi, N., Greenlaw, J. L., Yamamoto, M., & Kensler, T. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8786-8794.2003 · Cited by 500
Jain, A. K., & Jaiswal, A. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611336200 · Cited by 483
The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
Innamorato, N. G., Rojo, A. I., García-Yagüe, À. J., Yamamoto, M., de Ceballos, M. L., & Cuadrado, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.680 · Cited by 480
Vargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A., & Johnson, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4099-08.2008 · Cited by 479
The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
Jung, K.-A., & Kwak, M.-K. (2010) · Molecules · doi:10.3390/molecules15107266 · Cited by 474
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
Tong, K. I., Kobayashi, A., Katsuoka, F., & Yamamoto, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.164 · Cited by 473
Zbarsky, V., Datla, K. P., Parkar, S., Rai, D. K., Aruoma, O. I., & Dexter, D. T. (2005) · Free Radical Research · doi:10.1080/10715760500233113 · Cited by 462
Rezai-Zadeh, K., Arendash, G. W., Hou, H., Fernandez, F., Jensen, M., Runfeldt, M., Shytle, R. D., & Tan, J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.107 · Cited by 459
Chinta, S. J., Mallajosyula, J. K., Rane, A., & Andersen, J. K. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.061 · Cited by 449
The pathogenesis of cell death in Parkinson's disease
Jenner, P., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 446
Yang, C., Zhang, X., Fan, H., & Liu, Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.009 · Cited by 443
N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking
Orr, A. L., Li, S., Wang, C.-E., Li, H., Wang, J., Rong, J., Xu, X., Mastroberardino, P. G., Greenamyre, J. T., & Li, X.-J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0106-08.2008 · Cited by 430
Chen, C.-Y., Jang, J.-H., Li, M.-H., & Surh, Y.-J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.237 · Cited by 428
Rushmore, T. H., King, R. G., Paulson, K. E., & Pickett, C. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3826 · Cited by 423
Mitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406
Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death
Darios, F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.5.517 · Cited by 403
Nrf2 signaling and cell survival
Niture, S. K., Kaspar, J. W., Shen, J., & Jaiswal, A. K. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.06.009 · Cited by 398
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A., Curry, K. J., Buford, J. P., Khan, I., Netzer, W. J., Xu, H., & Butko, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182425199 · Cited by 398
Satoh, T., Kosaka, K., Itoh, K., Kobayashi, A., Yamamoto, M., Shimojo, Y., Kitajima, C., Cui, J., Kamins, J., Okamoto, S., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05039.x · Cited by 393
Schapira, A. H. V., Olanow, C. W., Greenamyre, J. T., & Bezard, E. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61010-2 · Cited by 392
Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease
Frijns, C. J. M., & Kappelle, L. J. (2002) · Stroke · doi:10.1161/01.str.0000021902.33129.69 · Cited by 390
Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
Jadidi‐Niaragh, F., & Mirshafiey, A. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02536.x · Cited by 384
The cholinergic anti-inflammatory pathway: A critical review
Martelli, D., McKinley, M. J., & McAllen, R. M. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.12.007 · Cited by 384
Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis
Dasuri, K., Zhang, L., & Keller, J. N. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.016 · Cited by 371
Brouillet, E., Jacquard, C., Bizat, N., & Blum, D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03515.x · Cited by 364
Sun, Z., Huang, Z., & Zhang, D. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006588 · Cited by 362
Zipp, F., & Aktas, O. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.006 · Cited by 348
Wilms, H., Sievers, J., Rickert, U., Rostami-Yazdi, M., Mrowietz, U., & Lucius, R. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-30 · Cited by 344
Melatonin signaling and cell protection function
Luchetti, F., Canonico, B., Betti, M., Arcangeletti, M., Pilolli, F., Piroddi, M., Canesi, L., Papa, S., & Galli, F. (2010) · The FASEB Journal · doi:10.1096/fj.10-154450 · Cited by 341
Disruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334
Habitual intake of dietary flavonoids and risk of Parkinson disease
Gao, X., Cassidy, A., Schwarzschild, M. A., Rimm, E. B., & Ascherio, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31824f7fc4 · Cited by 332
Nakaso, K., Yano, H., Fukuhara, Y., Takeshima, T., Wada-Isoe, K., & Nakashima, K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00517-9 · Cited by 326
Radical changes in multiple sclerosis pathogenesis
van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 322
van Horssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C. D., van der Valk, P., & de Vries, H. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.023 · Cited by 318
Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway
Yu, M., Li, H., Liu, Q., Liu, F., Tang, L., Li, C., Yuan, Y., Zhan, Y., Xu, W., Li, W., et al. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.01.014 · Cited by 317
Numazawa, S., Ishikawa, M., Yoshida, A., Tanaka, S., & Yoshida, T. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2003 · Cited by 317
Oxidative Damage in Huntington's Disease Pathogenesis
Browne, S. E., & Beal, M. F. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2061 · Cited by 310
Reactive oxygen species and ischemic cerebrovascular disease
Olmez, I., & Ozyurt, H. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2011.11.009 · Cited by 306
Keum, Y.-S., Yu, S., Chang, P. P.-J., Yuan, X., Kim, J.-H., Xu, C., Han, J., Agarwal, A., & Kong, A.-N. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3513 · Cited by 303
Oxidative and nitrosative stress in Parkinson's disease
Tsang, A. H. K., & Chung, K. K. K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.006 · Cited by 300
The molecular basis of neurodegeneration in multiple sclerosis
Lassmann, H., & van Horssen, J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.004 · Cited by 294
Dhakshinamoorthy, S., & Jaiswal, A. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204506 · Cited by 293
Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
Gan, L., & Johnson, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.011 · Cited by 288
Incidence of Alzheimer’s disease in a rural community in India: The Indo–US Study
Chandra, V., Pandav, R., Dodge, H. H., Johnston, J. M., Belle, S. H., DeKosky, S. T., & Ganguli, M. (2001) · Neurology · doi:10.1212/wnl.57.6.985 · Cited by 284
Benzi, G., & Moretti, A. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00244-e · Cited by 283
Liby, K., Hock, T., Yore, M. M., Suh, N., Place, A. E., Risingsong, R., Williams, C. R., Royce, D. B., Honda, T., Honda, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4539 · Cited by 283
Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue Inflammation
Jäger, A., & Kuchroo, V. K. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02432.x · Cited by 282
Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases
Tarozzi, A., Angeloni, C., Malaguti, M., Morroni, F., Hrelia, S., & Hrelia, P. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/415078 · Cited by 282
Cell adhesion molecules and ischemic stroke
Yilmaz, G., & Granger, D. N. (2008) · Neurological Research · doi:10.1179/174313208x341085 · Cited by 276
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 275
Schilling, S., Goelz, S., Linker, R., Luehder, F., & Gold, R. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03094.x · Cited by 271
Ali, T., Badshah, H., Kim, T. H., & Kim, M. O. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12194 · Cited by 268
Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs
Satoh, T., McKercher, S. R., & Lipton, S. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.022 · Cited by 267
Bennett, J., Basivireddy, J., Kollar, A., Biron, K. E., Reickmann, P., Jefferies, W. A., & McQuaid, S. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.011 · Cited by 265
Woo, S. Y., Kim, J. H., Moon, M. K., Han, S.-H., Yeon, S. K., Choi, J. W., Jang, B. K., Song, H. J., Kang, Y. G., Kim, J. W., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401788m · Cited by 263
Lastres-Becker, I., Ulusoy, A., Innamorato, N. G., Sahin, G., Rábano, A., Kirik, D., & Cuadrado, A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds143 · Cited by 263
Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8
Porquet, D., Casadesús, G., Bayod, S., Vicente, A., Canudas, A. M., Vilaplana, J., Pelegrí, C., Sanfeliu, C., Camins, A., Pallàs, M., et al. (2013) · AGE · doi:10.1007/s11357-012-9489-4 · Cited by 262
Olcese, J. M., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A., Runfeldt, M. J., Wang, L., Zhang, C., Lin, X., Zhang, G., et al. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00692.x · Cited by 260
Nuclear factor erythroid 2-related factor 2 protects against beta amyloid
Kanninen, K., Malm, T. M., Jyrkkänen, H.-K., Goldsteins, G., Keksa-Goldsteine, V., Tanila, H., Yamamoto, M., Ylä-Herttuala, S., Levonen, A.-L., & Koistinaho, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.010 · Cited by 255
Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata
Haraguchi, H., Ishikawa, H., Mizutani, K., Tamura, Y., & Kinoshita, T. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)10034-7 · Cited by 251
Ferrante, R. J., Shinobu, L. A., Schulz, J. B., Matthews, R. T., Thomas, C. E., Kowall, N. W., Gurney, M. E., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420309 · Cited by 250
GSK-3: A Bifunctional Role in Cell Death Pathways
Jacobs, K. M., Bhave, S. R., Ferraro, D. J., Jaboin, J. J., Hallahan, D. E., & Thotala, D. (2012) · International Journal of Cell Biology · doi:10.1155/2012/930710 · Cited by 247
The blood-brain barrier, chemokines and multiple sclerosis
Holman, D. W., Klein, R. S., & Ransohoff, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.019 · Cited by 247
The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Joshi, G., & A. Johnson, J. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912803252023 · Cited by 246
Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents
Zhao, J., Kobori, N., Aronowski, J., & Dash, P. K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.065 · Cited by 245
Müller, W. E., Eckert, A., Kurz, C., Eckert, G. P., & Leuner, K. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8141-5 · Cited by 243
Rojo, A. I., Sagarra, M. R. D., & Cuadrado, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05124.x · Cited by 241
Asayama, K., Yamadera, H., Ito, T., Suzuki, H., Kudo, Y., & Endo, S. (2003) · Journal of Nippon Medical School · doi:10.1272/jnms.70.334 · Cited by 241
Heme oxygenase expression in human central nervous system disorders
Schipper, H. M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.015 · Cited by 237
Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations
Müftüoglu, M., Elibol, B., Dalmızrak, Ö., Ercan, A., Kulaksız, G., Ögüs, H., Dalkara, T., & Özer, N. (2004) · Movement Disorders · doi:10.1002/mds.10695 · Cited by 237
The Flavanol (−)-Epicatechin Prevents Stroke Damage through the Nrf2/HO1 Pathway
Shah, Z. A., Li, R.-C., Ahmad, A. S., Kensler, T. W., Yamamoto, M., Biswal, S., & Doré, S. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.53 · Cited by 236
Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?
Witte, M. E., Geurts, J. J. G., de Vries, H. E., van der Valk, P., & van Horssen, J. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.05.014 · Cited by 235
Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts
Kapeta, S., Chondrogianni, N., & Gonos, E. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031575 · Cited by 234
Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation
Reynolds, J. M., Martinez, G. J., Chung, Y., & Dong, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120585109 · Cited by 234
de Jong, R., Bezemer, A. C., Zomerdijk, T. P. L., van de Pouw‐Kraan, T., Ottenhoff, T. H. M., & Nibbering, P. H. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260916 · Cited by 226
Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase
Chéret, C., Gervais, A., Lelli, A., Colin, C., Amar, L., Ravassard, P., Mallet, J., Cumano, A., Krause, K.-H., & Mallat, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3568-08.2008 · Cited by 225
Enhanced number and activity of mitochondria in multiple sclerosis lesions
Witte, M. E., Bø, L., Rodenburg, R. J., Belien, J. A., Musters, R., Hazes, T., Wintjes, L. T., Smeitink, J. A., Geurts, J. J., De Vries, H. E., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2582 · Cited by 225
Neuronal Apoptosis in Neurodegeneration
Okouchi, M., Ekshyyan, O., Maracine, M., & Aw, T. Y. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1511 · Cited by 218
Schimrigk, S., Brune, N., Hellwig, K., Lukas, C., Bellenberg, B., Rieks, M., Hoffmann, V., Pöhlau, D., & Przuntek, H. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01292.x · Cited by 217
Chang, J., Rimando, A., Pallas, M., Camins, A., Porquet, D., Reeves, J., Shukitt-Hale, B., Smith, M. A., Joseph, J. A., & Casadesus, G. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.015 · Cited by 217
Mrowietz, Christophers, & Aci, A. F. T. G. F. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03034.x · Cited by 215
Pi, J., Bai, Y., Reece, J. M., Williams, J., Liu, D., Freeman, M. L., Fahl, W. E., Shugar, D., Liu, J., Qu, W., et al. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.001 · Cited by 213
Lou, H., Jing, X., Wei, X., Shi, H., Ren, D., & Zhang, X. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.026 · Cited by 212
The pathogenesis of cell death in Parkinson's disease – 2007
Olanow, C. W. (2007) · Movement Disorders · doi:10.1002/mds.21675 · Cited by 211
Wang, S.-J., Wang, K.-Y., & Wang, W.-C. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.019 · Cited by 210
Neymotin, A., Calingasan, N. Y., Wille, E., Naseri, N., Petri, S., Damiano, M., Liby, K. T., Risingsong, R., Sporn, M., Beal, M. F., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.027 · Cited by 210
Johnson, D. A., Amirahmadi, S., Ward, C., Fabry, Z., & Johnson, J. A. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfp274 · Cited by 203
Jiang, D., Men, L., Wang, J., Zhang, Y., Chickenyen, S., Wang, Y., & Zhou, F. (2007) · Biochemistry · doi:10.1021/bi700508n · Cited by 202
Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
Lovett-Racke, A. E., Yang, Y., & Racke, M. K. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.05.012 · Cited by 201
Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment
SCHIPPER, H., BENNETT, D., LIBERMAN, A., BIENIAS, J., SCHNEIDER, J., KELLY, J., & ARVANITAKIS, Z. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.016 · Cited by 199
Neuronal cell death in Huntington’s disease: a potential role for dopamine
Jakel, R. J., & Maragos, W. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01568-x · Cited by 197
Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress
Juurlink, B. H. J., Thorburne, S. K., & Hertz, L. (1998) · Glia · doi:10.1002/(sici)1098-1136(199804)22:4<371::aid-glia6>3.0.co;2-6 · Cited by 196
Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice
Li, L., Zhang, X., Cui, L., Wang, L., Liu, H., Ji, H., & Du, Y. (2013) · Brain Research · doi:10.1016/j.brainres.2012.12.032 · Cited by 192
Targets for neuroprotection in Parkinson's disease
Yacoubian, T. A., & Standaert, D. G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.009 · Cited by 188
Red Wine Ingredient Resveratrol Protects from β-Amyloid Neurotoxicity
Savaskan, E., Olivieri, G., Meier, F., Seifritz, E., Wirz-Justice, A., & Müller-Spahn, F. (2003) · Gerontology · doi:10.1159/000073766 · Cited by 182
Tufekci, K. U., Civi Bayin, E., Genc, S., & Genc, K. (2011) · Parkinson's Disease · doi:10.4061/2011/314082 · Cited by 182
Effect of Antioxidant Flavanone, Naringenin, from Citrus junos on Neuroprotection
Heo, H. J., Kim, D.-O., Shin, S. C., Kim, M. J., Kim, B. G., & Shin, D.-H. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf035079g · Cited by 182
Xie, L., Li, X.-K., Funeshima-Fuji, N., Kimura, H., Matsumoto, Y., Isaka, Y., & Takahara, S. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.01.025 · Cited by 179
Morroni, F., Tarozzi, A., Sita, G., Bolondi, C., Zolezzi Moraga, J. M., Cantelli-Forti, G., & Hrelia, P. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.03.004 · Cited by 179
Sarlette, A., Krampfl, K., Grothe, C., Neuhoff, N. V., Dengler, R., & Petri, S. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818b4906 · Cited by 178
Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra
Muiswinkel, F. L. V., de Vos, R. A. I., Bol, J. G. J. M., Andringa, G., Steur, E. N. H. J., Ross, D., Siegel, D. M., & Drukarch, B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.010 · Cited by 176
Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
Ellrichmann, G., Petrasch‐Parwez, E., Lee, D.-H., Reick, C., Arning, L., Saft, C., Gold, R., & Linker, R. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016172 · Cited by 176
Sriram, N., Kalayarasan, S., & Sudhandiran, G. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.12.010 · Cited by 173
Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections
Cuadrado, A., & Rojo, A. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597407 · Cited by 173
The Immunopathophysiology of Multiple Sclerosis
Wu, G. F., & Alvarez, E. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2010.12.009 · Cited by 172
Yang, L., Calingasan, N. Y., Thomas, B., Chaturvedi, R. K., Kiaei, M., Wille, E. J., Liby, K. T., Williams, C., Royce, D., Risingsong, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005757 · Cited by 172
Kaidery, N. A., Banerjee, R., Yang, L., Smirnova, N. A., Hushpulian, D. M., Liby, K. T., Williams, C. R., Yamamoto, M., Kensler, T. W., Ratan, R. R., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4491 · Cited by 170
Stack, C., Ho, D., Wille, E., Calingasan, N. Y., Williams, C., Liby, K., Sporn, M., Dumont, M., & Beal, M. F. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.017 · Cited by 169
Ozarowski, M., Mikolajczak, P. L., Bogacz, A., Gryszczynska, A., Kujawska, M., Jodynis-Liebert, J., Piasecka, A., Napieczynska, H., Szulc, M., Kujawski, R., et al. (2013) · Fitoterapia · doi:10.1016/j.fitote.2013.09.012 · Cited by 169
Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models
Lassmann, H. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.10.009 · Cited by 169
Lee, H., Bae, J. H., & Lee, S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20193 · Cited by 168
Pollari, E., Goldsteins, G., Bart, G., Koıstınaho, J., & Giniatullin, R. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00131 · Cited by 168
Nair, S., Doh, S. T., Chan, J. Y., Kong, A.-N., & Cai, L. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604703 · Cited by 167
Where are we with probucol: A new life for an old drug?
Yamashita, S., & Matsuzawa, Y. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.002 · Cited by 167
Zeng, C., Zhong, P., Zhao, Y., Kanchana, K., Zhang, Y., Khan, Z. A., Chakrabarti, S., Wu, L., Wang, J., & Liang, G. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.10.002 · Cited by 166
Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model
Kim, H. V., Kim, H. Y., Ehrlich, H. Y., Choi, S. Y., Kim, D. J., & Kim, Y. S. (2012) · Amyloid · doi:10.3109/13506129.2012.751367 · Cited by 163
Buckley, M. M.-T., Goa, K. L., Price, A. H., & Brogden, R. N. (1989) · Drugs · doi:10.2165/00003495-198937060-00002 · Cited by 162
The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice
Koh, S.-H., Lee, S. M., Kim, H. Y., Lee, K.-Y., Lee, Y. J., Kim, H.-T., Kim, J., Kim, M.-H., Hwang, M. S., Song, C., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.056 · Cited by 161
Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro
Ogawa, N., Tanaka, K.-I., Asanuma, M., Kawai, M., Masumizu, T., Kohno, M., & Mori, A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90969-5 · Cited by 160
Role of oxidative DNA damage in mitochondrial dysfunction and Huntington’s disease pathogenesis
Ayala‐Peña, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.017 · Cited by 159
Neuroprotection After Stroke by Targeting NOX4 As a Source of Oxidative Stress
Radermacher, K. A., Wingler, K., Langhauser, F., Altenhöfer, S., Kleikers, P. W. M., Hermans, J. J. R., de Angelis, M. H., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4797 · Cited by 159
Feng, X., Liang, N., Zhu, D., Gao, Q., Peng, L., Dong, H., Yue, Q., Liu, H., Bao, L., Zhang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059888 · Cited by 158
Gao, S., Duan, X., Wang, X., Dong, D., Liu, D., Li, X., Sun, G., & Li, B. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.032 · Cited by 158
Ribeiro, M., Rosenstock, T. R., Oliveira, A. M., Oliveira, C. R., & Rego, A. C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.023 · Cited by 157
Wang, D., Wang, Y., Wan, X., Yang, C. S., & Zhang, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.12.018 · Cited by 156
Lin, S. X., Lisi, L., Russo, C. D., Polak, P. E., Sharp, A. J., Weinberg, G. L., Kalinin, S., & Feinstein, D. L. (2011) · ASN NEURO · doi:10.1042/an20100033 · Cited by 156
Xu, Z., Chen, S., Li, X., Luo, G., Li, L., & Le, W. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9166-z · Cited by 152
Curcumin Promotes A-beta Fibrillation and Reduces Neurotoxicity in Transgenic Drosophila
Caesar, I., Jonson, M., Nilsson, K. P. R., Thor, S., & Hammarström, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031424 · Cited by 151
Innamorato, N. G., Jaźwa, A., Rojo, A. I., García, C., Fernández‐Ruíz, J., Grochot‐Przeczek, A., Stachurska, A., Józkowicz, A., Dulak, J., & Cuadrado, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011838 · Cited by 150
Minghetti, L., Carnevale, D., & Simone, R. D. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707783399193 · Cited by 146
Therapeutic application of melatonin in mild cognitive impairment.
Cardinali, D. P., Vigo, D. E., Olivar, N., Vidal, M. F., Furio, A. M., & Brusco, L. I. (2012) · Europe PMC (PubMed Central) · Cited by 145
Pehar, M., Vargas, M. R., Robinson, K. M., Cassina, P., Díaz‐Amarilla, P., Hagen, T. M., Radí, R., Barbeito, L., & Beckman, J. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0823-07.2007 · Cited by 145
Lim, J. H., Kim, K., Kim, S. W., Hwang, O., & Choi, H. J. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.004 · Cited by 145
Cited by
Sies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Sivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
Nrf2/Keap1/ARE signaling: Towards specific regulation
Ulasov, A. V., Rosenkranz, A. A., Georgiev, G. P., & Sobolev, A. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120111 · Cited by 508
Metadata
- Authors
- Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 157
- Pages
- 84-104
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2175833749
- Cited by
- 678
- References
- 331
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.